サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1566852

アセチル-L-カルニチン（ALC）市場：タイプ別、流通チャネル別：世界の機会分析と産業予測、2024～2033年

Acetyl-L Carnitine (ALC) Market By Type (Capsules, Tablets, Others) , By Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, Online Providers) : Global Opportunity Analysis and Industry Forecast, 2024-2033

出版日
ページ情報
英文 211 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
アセチル-L-カルニチン（ALC）市場：タイプ別、流通チャネル別：世界の機会分析と産業予測、2024～2033年
出版日: 2024年07月10日
発行: Allied Market Research
ページ情報: 英文 211 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

アセチル-Lカルニチン（ALC）市場

アセチル-L-カルニチン（ALC）市場は、2023年に5,810万米ドルと評価され、2024～2033年にかけて5.3%のCAGRで成長し、2033年には9,750万米ドルに達すると予測されています。

アセチル-L-カルニチン（ALC）は、アミノ酸L-カルニチンから人体内で合成される天然化合物です。ALCは、脂肪酸のミトコンドリアへの移行を促進し、そこで脂肪酸が酸化されてエネルギーを生成するため、細胞のエネルギー形成に不可欠な役割を果たしています。血漿中のエステラーゼはALCをカルニチンに分解し、カルニチンは脂肪酸のトランスミッションに利用されます。さらに、ALCはアセチルコリンの生成に関与するため、記憶と認知機能に寄与します。抗酸化作用と神経細胞の健康サポートにより、ALCは神経変性疾患に有益です。

アセチル-L-カルニチン（ALC）はサプリメントに不可欠な成分であるため、健康サプリメントの認知度と摂取量の増加がアセチル-L-カルニチン（ALC）市場の主要促進要因となっています。さらに、人口動態が世界的に高齢者グループにシフトするにつれ、認知機能をサポートし、加齢に関連する健康上の懸念を軽減する医薬品への需要が急増するため、ALCの需要が高まっています。現在、ALCの摂取動向はアスリートの間で顕在化しており、この化合物は高強度のスポーツ・パフォーマンス中にポジティブな結果をもたらすことが確認されています。ALCによる好結果は、体内のミトコンドリアのアセチル-CoA/CoA比を維持する役割に起因しています。

しかし、健康補助食品におけるALCの使用にはいくつかの保健規制があり、その遵守は課題です。これがアセチル-L-カルニチン（ALC）市場の成長を抑制しています。例えば、米国栄養補助食品学会（Academy of Nutrition and Dietetics）による栄養補助食品のラベルデータベースである国民健康栄養調査（National Health and Nutrition Examination Survey）では、健康補助食品の配合に含まれるさまざまな成分の使用量に関する厳しいガイドラインが課されています。ALCを含む栄養成分に対するこのような厳格な規制は、過剰摂取による深刻な結果を防ぐために必要です。ALCの過剰摂取は、高血圧、高トリグリセリド、双極性障害を患う人の精神病を引き起こすことが報告されています。

セグメントレビュー

アセチル-L-カルニチン（ALC）市場は、タイプ、流通チャネル、地域に区分されます。タイプ別では、市場はカプセル、錠剤、その他に分けられます。流通チャネル別では、病院薬局、ドラッグストア＆小売薬局、オンラインプロバイダーに分類されます。地域別では、北米、欧州、アジア太平洋、ラテンアメリカ・中東・アフリカで分析されます。

主要調査結果

タイプ別では、錠剤セグメントが2023年の最高株主でした。

流通チャネル別では、ドラッグストア＆小売薬局セグメントが2023年に高い市場シェアを占めました。

地域別では、北米が2033年までに最も高い収益を上げると予測されています。

本レポートのカスタマイズが可能です。

  • 規制ガイドライン
  • クライアントの関心に応じた企業プロファイルの追加
  • 国別または地域別の追加分析-市場規模と予測
  • 企業プロファイルの拡大リスト
  • 過去の市場データ
  • 主要参入企業の詳細（所在地、連絡先、サプライヤー/ベンダーネットワークなどを含む、エクセル形式）

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場情勢

  • 市場の定義と範囲
  • 主要調査結果
    • 主要投資機会
    • 主要成功戦略
  • ポーターのファイブフォース分析
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会

第4章 アセチル-L-カルニチン（ALC）市場：タイプ別

  • 市場概要
  • カプセル
  • 錠剤
  • その他

第5章 アセチル-L-カルニチン（ALC）市場：流通チャネル別

  • 市場概要
  • 病院薬局
  • ドラッグストア＆小売薬局
  • オンラインプロバイダー

第6章 アセチル-L-カルニチン（ALC）市場：地域別

  • 市場概要
  • 北米
    • 主要市場動向と機会
    • 米国のアセチル-L-カルニチン（ALC）市場
    • カナダのアセチル-L-カルニチン（ALC）市場
    • メキシコのアセチル-L-カルニチン（ALC）市場
  • 欧州
    • 主要市場動向と機会
    • ドイツのアセチル-L-カルニチン（ALC）市場
    • フランスのアセチル-L-カルニチン（ALC）市場
    • 英国のアセチル-L-カルニチン（ALC）市場
    • イタリアのアセチル-L-カルニチン（ALC）市場
    • スペインのアセチル-L-カルニチン（ALC）市場
    • その他の欧州のアセチル-L-カルニチン（ALC）市場
  • アジア太平洋
    • 主要市場動向と機会
    • 日本のアセチル-L-カルニチン（ALC）市場
    • 中国のアセチル-L-カルニチン（ALC）市場
    • インドのアセチル-Lカルニチン（ALC）市場
    • オーストラリアのアセチル-Lカルニチン（ALC）市場
    • 韓国のアセチル-Lカルニチン（ALC）市場
    • その他のアジア太平洋のアセチル-L-カルニチン（ALC）市場
  • ラテンアメリカ・中東・アフリカ
    • 主要市場動向と機会
    • ブラジルのアセチル-L-カルニチン（ALC）市場
    • サウジアラビアのアセチル-L-カルニチン（ALC）市場
    • 南アフリカのアセチル-L-カルニチン（ALC）市場
    • その他のラテンアメリカ・中東・アフリカのアセチル-Lカルニチン（ALC）市場

第7章 競合情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10社の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • 主要企業のポジショニング（2023年）

第8章 企業プロファイル

  • Nature's Bounty
  • Swanson
  • Namedsport S.r.l.
  • Intas Pharmaceuticals Ltd.
  • NutriJa Lifesciences
  • Chemkart
  • Foodchem International Corporation
  • SimplySupplements
  • GNC Holdings, LLC
  • Solaray
目次
Product Code: A108370

Acetyl-L Carnitine (ALC) Market

The acetyl-L carnitine (ALC) market was valued at $58.1 million in 2023 and is projected to reach $97.5 million by 2033, growing at a CAGR of 5.3% from 2024 to 2033.

Acetyl-L-carnitine (ALC) is a natural compound synthesized inside the human body from the amino acid L-carnitine. ALC plays an essential role in cellular energy formation as it facilitates the transfer of fatty acids into the mitochondria, where they are oxidized to produce energy. Plasma esterases break down ALC in the blood into carnitine, which is then utilized for the transmission of fatty acids. In addition, ALC contributes to memory and cognitive function as it is involved in acetylcholine production. The antioxidant properties and nerve cell health support make ALC beneficial in neurodegenerative conditions.

Increase in awareness and uptake of health supplements is a key driver of the acetyl-L carnitine (ALC) market as the compound is an essential element of the supplements. Furthermore, as the demographics shift toward old age groups globally, the demand for ALC is rising due to surge in the requirement for medications that support cognitive function and mitigate age-related health concerns. Currently, the trend of the uptake of ALC is emerging among athletes as the compound has been identified to deliver positive outcomes during high-intensity sports performances. The positive results by ALC are attributed to its role in maintaining the mitochondrial acetyl-CoA/CoA ratio inside the body.

However, the usage of ALC in health supplements is subject to several health regulations, compliance with which is a challenging task. This restrains the growth of the acetyl-L carnitine (ALC) market. For instance, the National Health and Nutrition Examination Survey, a dietary supplement label database, by the Academy of Nutrition and Dietetics in the U.S. has imposed stringent guidelines pertaining to usage quantities of different components present in the formulations of health supplements. Such rigorous regulations over dietary components, including ALC, are required to prevent the severe outcomes of overdose. Overdoses of ALC have been reported to cause high blood pressure, high triglycerides, and psychosis in individuals suffering from bipolar disorder.

Segment Review

The acetyl-L carnitine (ALC) market is segmented into type, distribution channel, and region. On the basis of type, the market is divided into capsules, tablets, and others. As per distribution channel, it is classified into hospital pharmacies, drug stores & retail pharmacies, and online providers. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of type, the tablets segment was the highest shareholder in 2023.

As per distribution channel, the drug stores & retail pharmacies segment accounted for a high market share in 2023.

Region wise, North America is projected to be the highest revenue generator by 2033.

Competition Analysis

The major players operating in the global acetyl-L carnitine (ALC) market include Nature's Bounty, Swanson, Namedsport S.r.l., Intas Pharmaceuticals Ltd., NutriJa Lifesciences, Chemkart, Foodchem International Corporation, SimplySupplements , GNC Holdings, LLC, and Solaray. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Type

  • Capsules
  • Tablets
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Drug Stores and Retail Pharmacies
  • Online Providers

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Nature's Bounty
    • Swanson
    • Namedsport S.r.l.
    • Intas Pharmaceuticals Ltd.
    • NutriJa Lifesciences
    • Chemkart
    • Foodchem International Corporation
    • SimplySupplements
    • GNC Holdings, LLC
    • Solaray

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: ACETYL-L CARNITINE (ALC) MARKET, BY TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Type
  • 4.2. Capsules
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Tablets
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Others
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country

CHAPTER 5: ACETYL-L CARNITINE (ALC) MARKET, BY DISTRIBUTION CHANNEL

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Distribution Channel
  • 5.2. Hospital Pharmacies
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Drug Stores And Retail Pharmacies
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Online Providers
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country

CHAPTER 6: ACETYL-L CARNITINE (ALC) MARKET, BY REGION

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Region
  • 6.2. North America
    • 6.2.1. Key Market Trends and Opportunities
    • 6.2.2. Market Size and Forecast, By Type
    • 6.2.3. Market Size and Forecast, By Distribution Channel
    • 6.2.4. Market Size and Forecast, By Country
    • 6.2.5. U.S. Acetyl-L Carnitine (ALC) Market
      • 6.2.5.1. Market Size and Forecast, By Type
      • 6.2.5.2. Market Size and Forecast, By Distribution Channel
    • 6.2.6. Canada Acetyl-L Carnitine (ALC) Market
      • 6.2.6.1. Market Size and Forecast, By Type
      • 6.2.6.2. Market Size and Forecast, By Distribution Channel
    • 6.2.7. Mexico Acetyl-L Carnitine (ALC) Market
      • 6.2.7.1. Market Size and Forecast, By Type
      • 6.2.7.2. Market Size and Forecast, By Distribution Channel
  • 6.3. Europe
    • 6.3.1. Key Market Trends and Opportunities
    • 6.3.2. Market Size and Forecast, By Type
    • 6.3.3. Market Size and Forecast, By Distribution Channel
    • 6.3.4. Market Size and Forecast, By Country
    • 6.3.5. Germany Acetyl-L Carnitine (ALC) Market
      • 6.3.5.1. Market Size and Forecast, By Type
      • 6.3.5.2. Market Size and Forecast, By Distribution Channel
    • 6.3.6. France Acetyl-L Carnitine (ALC) Market
      • 6.3.6.1. Market Size and Forecast, By Type
      • 6.3.6.2. Market Size and Forecast, By Distribution Channel
    • 6.3.7. UK Acetyl-L Carnitine (ALC) Market
      • 6.3.7.1. Market Size and Forecast, By Type
      • 6.3.7.2. Market Size and Forecast, By Distribution Channel
    • 6.3.8. Italy Acetyl-L Carnitine (ALC) Market
      • 6.3.8.1. Market Size and Forecast, By Type
      • 6.3.8.2. Market Size and Forecast, By Distribution Channel
    • 6.3.9. Spain Acetyl-L Carnitine (ALC) Market
      • 6.3.9.1. Market Size and Forecast, By Type
      • 6.3.9.2. Market Size and Forecast, By Distribution Channel
    • 6.3.10. Rest of Europe Acetyl-L Carnitine (ALC) Market
      • 6.3.10.1. Market Size and Forecast, By Type
      • 6.3.10.2. Market Size and Forecast, By Distribution Channel
  • 6.4. Asia-Pacific
    • 6.4.1. Key Market Trends and Opportunities
    • 6.4.2. Market Size and Forecast, By Type
    • 6.4.3. Market Size and Forecast, By Distribution Channel
    • 6.4.4. Market Size and Forecast, By Country
    • 6.4.5. Japan Acetyl-L Carnitine (ALC) Market
      • 6.4.5.1. Market Size and Forecast, By Type
      • 6.4.5.2. Market Size and Forecast, By Distribution Channel
    • 6.4.6. China Acetyl-L Carnitine (ALC) Market
      • 6.4.6.1. Market Size and Forecast, By Type
      • 6.4.6.2. Market Size and Forecast, By Distribution Channel
    • 6.4.7. India Acetyl-L Carnitine (ALC) Market
      • 6.4.7.1. Market Size and Forecast, By Type
      • 6.4.7.2. Market Size and Forecast, By Distribution Channel
    • 6.4.8. Australia Acetyl-L Carnitine (ALC) Market
      • 6.4.8.1. Market Size and Forecast, By Type
      • 6.4.8.2. Market Size and Forecast, By Distribution Channel
    • 6.4.9. South Korea Acetyl-L Carnitine (ALC) Market
      • 6.4.9.1. Market Size and Forecast, By Type
      • 6.4.9.2. Market Size and Forecast, By Distribution Channel
    • 6.4.10. Rest of Asia-Pacific Acetyl-L Carnitine (ALC) Market
      • 6.4.10.1. Market Size and Forecast, By Type
      • 6.4.10.2. Market Size and Forecast, By Distribution Channel
  • 6.5. LAMEA
    • 6.5.1. Key Market Trends and Opportunities
    • 6.5.2. Market Size and Forecast, By Type
    • 6.5.3. Market Size and Forecast, By Distribution Channel
    • 6.5.4. Market Size and Forecast, By Country
    • 6.5.5. Brazil Acetyl-L Carnitine (ALC) Market
      • 6.5.5.1. Market Size and Forecast, By Type
      • 6.5.5.2. Market Size and Forecast, By Distribution Channel
    • 6.5.6. Saudi Arabia Acetyl-L Carnitine (ALC) Market
      • 6.5.6.1. Market Size and Forecast, By Type
      • 6.5.6.2. Market Size and Forecast, By Distribution Channel
    • 6.5.7. South Africa Acetyl-L Carnitine (ALC) Market
      • 6.5.7.1. Market Size and Forecast, By Type
      • 6.5.7.2. Market Size and Forecast, By Distribution Channel
    • 6.5.8. Rest of LAMEA Acetyl-L Carnitine (ALC) Market
      • 6.5.8.1. Market Size and Forecast, By Type
      • 6.5.8.2. Market Size and Forecast, By Distribution Channel

CHAPTER 7: COMPETITIVE LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top Winning Strategies
  • 7.3. Product Mapping of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Top Player Positioning, 2023

CHAPTER 8: COMPANY PROFILES

  • 8.1. Nature's Bounty
    • 8.1.1. Company Overview
    • 8.1.2. Key Executives
    • 8.1.3. Company Snapshot
    • 8.1.4. Operating Business Segments
    • 8.1.5. Product Portfolio
    • 8.1.6. Business Performance
    • 8.1.7. Key Strategic Moves and Developments
  • 8.2. Swanson
    • 8.2.1. Company Overview
    • 8.2.2. Key Executives
    • 8.2.3. Company Snapshot
    • 8.2.4. Operating Business Segments
    • 8.2.5. Product Portfolio
    • 8.2.6. Business Performance
    • 8.2.7. Key Strategic Moves and Developments
  • 8.3. Namedsport S.r.l.
    • 8.3.1. Company Overview
    • 8.3.2. Key Executives
    • 8.3.3. Company Snapshot
    • 8.3.4. Operating Business Segments
    • 8.3.5. Product Portfolio
    • 8.3.6. Business Performance
    • 8.3.7. Key Strategic Moves and Developments
  • 8.4. Intas Pharmaceuticals Ltd.
    • 8.4.1. Company Overview
    • 8.4.2. Key Executives
    • 8.4.3. Company Snapshot
    • 8.4.4. Operating Business Segments
    • 8.4.5. Product Portfolio
    • 8.4.6. Business Performance
    • 8.4.7. Key Strategic Moves and Developments
  • 8.5. NutriJa Lifesciences
    • 8.5.1. Company Overview
    • 8.5.2. Key Executives
    • 8.5.3. Company Snapshot
    • 8.5.4. Operating Business Segments
    • 8.5.5. Product Portfolio
    • 8.5.6. Business Performance
    • 8.5.7. Key Strategic Moves and Developments
  • 8.6. Chemkart
    • 8.6.1. Company Overview
    • 8.6.2. Key Executives
    • 8.6.3. Company Snapshot
    • 8.6.4. Operating Business Segments
    • 8.6.5. Product Portfolio
    • 8.6.6. Business Performance
    • 8.6.7. Key Strategic Moves and Developments
  • 8.7. Foodchem International Corporation
    • 8.7.1. Company Overview
    • 8.7.2. Key Executives
    • 8.7.3. Company Snapshot
    • 8.7.4. Operating Business Segments
    • 8.7.5. Product Portfolio
    • 8.7.6. Business Performance
    • 8.7.7. Key Strategic Moves and Developments
  • 8.8. SimplySupplements
    • 8.8.1. Company Overview
    • 8.8.2. Key Executives
    • 8.8.3. Company Snapshot
    • 8.8.4. Operating Business Segments
    • 8.8.5. Product Portfolio
    • 8.8.6. Business Performance
    • 8.8.7. Key Strategic Moves and Developments
  • 8.9. GNC Holdings, LLC
    • 8.9.1. Company Overview
    • 8.9.2. Key Executives
    • 8.9.3. Company Snapshot
    • 8.9.4. Operating Business Segments
    • 8.9.5. Product Portfolio
    • 8.9.6. Business Performance
    • 8.9.7. Key Strategic Moves and Developments
  • 8.10. Solaray
    • 8.10.1. Company Overview
    • 8.10.2. Key Executives
    • 8.10.3. Company Snapshot
    • 8.10.4. Operating Business Segments
    • 8.10.5. Product Portfolio
    • 8.10.6. Business Performance
    • 8.10.7. Key Strategic Moves and Developments